Congenital Heart Defect Devices Market Growth Outlook Indicating Expansion To $4.44 Billion By 2030
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Congenital Heart Defect Devices Market During The 2026–2030 Period?
The congenital heart defect devices market size has experienced significant growth in recent years. It is projected to expand from $3.11 billion in 2025 to $3.34 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. The historical expansion in this market can be attributed to the rising incidence of congenital heart defects, ongoing advancements in pediatric cardiac surgery, improved survival rates for congenital heart patients, the proliferation of specialized cardiac care centers, and a growing awareness regarding early congenital defect diagnosis.
The congenital heart defect devices market size is projected to undergo significant expansion in the coming years. It is poised to grow to $4.45 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This anticipated growth throughout the forecast period stems from an intensified focus on early diagnosis and intervention, an increasing need for minimally invasive pediatric cardiac treatments, the broadening accessibility of advanced cardiac care in emerging markets, a rising population of adults with congenital heart disease, and continuous innovation in implantable cardiac devices. Prominent trends for the forecast period include the increasing adoption of minimally invasive congenital heart procedures, greater utilization of transcatheter and implantable cardiac devices, an expanding emphasis on early-life and pediatric cardiac interventions, the wider application of device-based therapies for complex heart defects, and a growing demand for long-term cardiac monitoring and support devices.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18543&type=smp
What Important Drivers Are Powering The Congenital Heart Defect Devices Market Growth?
The rising adoption of minimally invasive procedures is projected to drive expansion in the congenital heart defect device market. These procedures entail surgical interventions conducted via small cuts or natural orifices, frequently employing specialized instruments and methods to lessen injury and improve recuperation. The uptick in minimally invasive procedures stems from technological progress, patient demand for less intrusive options, refined surgical approaches, and the advantages of quicker recovery and fewer complications. Devices for congenital heart defects are utilized in minimally invasive procedures, aiding in the diagnosis, treatment, and management of cardiac anomalies via methods employing smaller cuts or catheter-based strategies. An illustrative example is from June 2024, where the American Society of Plastic Surgeons, a US-based organization, reported that in 2023, plastic surgeries saw a 5% increase, and minimally invasive procedures grew by 7% year-over-year. Consequently, the growing commonness of minimally invasive procedures is a key impetus for the congenital heart defect devices market.
What Are The Major Segment Categories Within The Congenital Heart Defect Devices Market?
The congenital heart defect devices market covered in this report is segmented –
1) By Device Type: Catheters, Pacemakers, Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types
2) By Defect Type: Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types
3) By End user: Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users
Subsegments:
1) By Catheters: Balloon Catheters, Diagnostic Catheters, Guiding Catheters
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers
3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds
4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators)
5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders
6) By Other Device Types: Transcatheter Heart Valves, Ventricular Assist Devices (VADS)
What Trends Are Influencing The Congenital Heart Defect Devices Market?
Leading companies in the congenital heart defect devices market are increasingly adopting a strategic partnerships approach to develop innovative congenital heart defect devices. These strategic alliances support businesses in the congenital heart defect devices sector by combining resources and expertise, accelerating research and development efforts, expanding market reach, and expediting commercialization. Ultimately, this collaboration stimulates innovation and drives growth within the industry. For instance, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, collaborated with HeartX, an India-based MedTech firm, to enhance patient care in the cardiovascular sector. Through this partnership, Sahajanand Medical Technologies (SMT) strengthens its position in the congenital heart defect (CHD) space by integrating HeartX’s innovative solutions, such as the JOVE VB Stent. This strategic alliance allows SMT to offer advanced CHD devices that improve treatment efficacy, simplify procedures, and enhance patient outcomes.
Which Firms Are Competing In The Congenital Heart Defect Devices Market?
Major companies operating in the congenital heart defect devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc
Access The Complete Congenital Heart Defect Devices Market Report:
Which Region Is The Primary Market For The Congenital Heart Defect Devices Market?
North America was the largest region in the congenital heart defect devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Congenital Heart Defect Devices Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=18543&type=smp
Browse Through More Reports Similar to the Global Congenital Heart Defect Devices Market 2026, By The Business Research Company
Computed Tomography Ct Scanners Devices And Equipment Market Report 2026
Computed Tomography Ct Scanner Market Report 2026
Positron Emission Tomography Pet Scanners Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
